Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

5902 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
72-21 普海司 Bracco Imaging Italia s.r.l. Original drug approved in China Original drug imported to China The 72nd Batch of Reference Listed Drugs
72-22 新普乐可复 Astellas Pharma Europe B.V. Original drug approved in China Original drug imported to China The 72nd Batch of Reference Listed Drugs
71-1 SUBOXONE INDIVIOR INC Original drug not imported to China US Orange Book The 71st Batch of Reference Listed Drugs
71-2 SUBOXONE INDIVIOR INC Original drug not imported to China US Orange Book The 71st Batch of Reference Listed Drugs
71-3 SUBOXONE INDIVIOR INC Original drug not imported to China US Orange Book The 71st Batch of Reference Listed Drugs
71-4 SUBOXONE INDIVIOR INC Original drug not imported to China US Orange Book The 71st Batch of Reference Listed Drugs
71-5 Quviviq Idorsia Pharmaceuticals Ltd Original drug not imported to China US Orange Book The 71st Batch of Reference Listed Drugs
71-6 Quviviq Idorsia Pharmaceuticals Ltd Original drug not imported to China US Orange Book The 71st Batch of Reference Listed Drugs
71-7 Peridex 3M CO Original drug not imported to China US Orange Book The 71st Batch of Reference Listed Drugs
71-8 Otrivin comp GlaxoSmithKline Consumer Healthcare ApS Original drug not imported to China Approved in EU The 71st Batch of Reference Listed Drugs